New treatment welcome news for Parkinson's and stroke patients

July 11, 2012

(Medical Xpress) -- New research developed by The University of Queensland is set to change the future treatment of speech problems associated with stroke and Parkinson's disease.

The new treatment is promising news for people with speech and language disorders that result from diseases within the .

Professor Bruce Murdoch of the Centre for Neurogenic Communication Disorders Research within UQ's School of Health and said preliminary trials of the new treatment were positive in the effective treatment of these speech and language disorders.

The research has found a , transcranial (TMS), can be used to stimulate the brain with a series of delivered by a stimulating coil held over selected areas of the head.

Professor Murdoch said TMS featured a coil, shaped like a figure eight, that was held over the patient's head to “switch on part of the brain” in Parkinson's sufferers and “switch off” a different part in stroke victims.

“The non-invasive technology is proving very effective in treating long-term sufferers of stroke and Parkinson's disease, where traditional therapy approaches have proven ineffective,” he said.

“The brain can heal itself much better than we thought it could.

“Based on these findings, TMS would appear to have the potential to revolutionise the treatment of brain-based speech and language disorders with improved outcomes and quality of life for sufferers of neurological disease.”

Professor Murdoch said the trials have recorded positive results within a week to two months after treatment, with patients still recording improvement 12 months' post-stimulation.

“When present, these disorders have a serious impact on quality of life, often leading to an inability to communicate with family and friends, social isolation, loss of vocational standing and financial hardship,” he said.

“Unfortunately speech and language disorders associated with conditions such as stroke and Parkinson's disease have proven difficult to treat, and consequently many sufferers of these conditions experience long-term impairment of their ability to speak and communicate with others.”

Professor Murdoch, in collaboration with colleagues from the University of Hong Kong, is extending the research to include investigation of the use of TMS in the treatment of swallowing disorders post-, as well as its potential application in the treatment of brain-based voice problems.

Explore further: Magnetic treatment improves stroke patients' ability to communicate

Related Stories

Magnetic treatment improves stroke patients' ability to communicate

November 15, 2011
(Medical Xpress) -- Magnetic stimulation of the brain could help improve language skills of stroke survivors with aphasia, according to research by The University of Queensland.

Anti-inflammatory chemical could prevent stroke damage

December 5, 2011
(Medical Xpress) -- Drugs that block inflammation in the brain could help patients who have a stroke or a brain haemorrhage, Manchester scientists said today (5 December) at the British Society for Immunology Congress in ...

Research holds out hope for stroke patients

May 21, 2012
(Medical Xpress) -- People with a curious condition that causes them to apply make-up on only one side of their face, or ignore food on half of their plate, are playing a new role in understanding stroke recovery.

Recommended for you

Novel technique explains herbicide's link to Parkinson's disease

October 23, 2017
Northwestern Medicine scientists have used an innovative gene editing technique to identify the genes that may lead to Parkinson's disease after exposure to paraquat, a commonly-used herbicide.

Data, technology drive new approaches to Parkinson's care

October 23, 2017
Complex, multi-system diseases like Parkinson's have long posed challenges to both scientists and physicians. University of Rochester Medical Center (URMC) researchers are now reaching for new tools, such as algorithms, ...

Investigating the most common genetic contributor to Parkinson's disease

October 19, 2017
LRRK2 gene mutations are the most common genetic cause of Parkinson's disease (PD), but the normal physiological role of this gene in the brain remains unclear. In a paper published in Neuron, Brigham and Women's Hospital ...

Scientists solve 3-D structure of key defense protein against Parkinson's disease

October 5, 2017
Scientists at the University of Dundee have identified the structure of a key enzyme that protects the brain against Parkinson's disease.

Novel protein interactions explain memory deficits in Parkinson's disease

September 26, 2017
A study published in the journal Nature Neuroscience describes the identification of a novel molecular pathway that can constitute a therapeutic target for cognitive defects in Parkinson's disease. The study showed that abnormal ...

Psychosis in Parkinson's dementia—new treatment provides hope

September 25, 2017
New research involving King's College London and the University of Exeter has highlighted the benefits of a promising new treatment which could relieve psychosis in thousands of people with dementia related to Parkinson's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.